Research Analysts’ Price Target Changes for April 1st (AXTA, BRBY, DLN, DOC, FUTR, GNRC, HFG, NBR, NG, PRGS)

Research Analysts’ price target changes for Wednesday, April 1st:

Axalta Coating Systems (NYSE:AXTA) had its price target trimmed by Citigroup Inc. from $45.00 to $42.00. The firm currently has a buy rating on the stock.

Burberry Group (LON:BRBY) had its target price lowered by Deutsche Bank Aktiengesellschaft from GBX 1,550 to GBX 1,480. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Derwent London (LON:DLN) had its target price lowered by Berenberg Bank from GBX 2,296 to GBX 2,210. They currently have a buy rating on the stock.

Healthpeak Properties (NYSE:DOC) had its target price cut by Citigroup Inc. from $18.00 to $17.50. The firm currently has a neutral rating on the stock.

Future (LON:FUTR) had its price target cut by Deutsche Bank Aktiengesellschaft from GBX 1,875 to GBX 1,013. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Generac (NYSE:GNRC) had its price target increased by Canaccord Genuity Group Inc. from $275.00 to $300.00. They currently have a buy rating on the stock.

Hilton Food Group (LON:HFG) had its price target raised by Berenberg Bank from GBX 740 to GBX 790. They currently have a buy rating on the stock.

Nabors Industries (NYSE:NBR) had its target price raised by Citigroup Inc. from $85.00 to $89.00. The firm currently has a neutral rating on the stock.

National Grid (LON:NG) had its target price cut by Deutsche Bank Aktiengesellschaft from GBX 1,430 to GBX 1,370. The firm currently has a buy rating on the stock.

Progress Software (NASDAQ:PRGS) had its price target lowered by Citigroup Inc. from $60.00 to $46.00. The firm currently has a buy rating on the stock.

Rani Therapeutics (NASDAQ:RANI) had its price target cut by Canaccord Genuity Group Inc. from $9.00 to $5.00. The firm currently has a buy rating on the stock.

Sherwin-Williams (NYSE:SHW) had its price target lowered by Citigroup Inc. from $410.00 to $385.00. The firm currently has a buy rating on the stock.

Veris Residential (NYSE:VRE) had its target price raised by Citigroup Inc. from $16.00 to $19.00. Citigroup Inc. currently has a neutral rating on the stock.